Next Steps in the Development of Axatilimab
Corey Cutler, MD, MPH, and Hannah Choe, MD, provide future perspectives on the development of axatilimab for patients with chronic GVHD.
Video content above is prompted by the following questions:
- While axatilimab targets a novel pathway in cGVHD, what other unmet needs persist in managing this condition?
- What are the key challenges in improving overall outcomes and quality of life for patients with cGVHD?
- Are there any promising emerging therapies, combination approaches, or ongoing trials that could complement axatilimab's role in the cGVHD treatment landscape?
- Are there any promising emerging therapies, combination approaches, or ongoing trials that could complement axatilimab's role in the cGVHD treatment landscape?
- What are the key challenges in improving overall outcomes and quality of life for patients with cGVHD?
Recent Videos
Related Content
